First Time Loading...

Abbvie Inc
NYSE:ABBV

Watchlist Manager
Abbvie Inc Logo
Abbvie Inc
NYSE:ABBV
Watchlist
Price: 167.8 USD -1.03% Market Closed
Updated: Apr 25, 2024
Section:
 

Relative Value

The Relative Value of one ABBV stock under the Base Case scenario is 137.01 USD. Compared to the current market price of 167.8 USD, Abbvie Inc is Overvalued by 18%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ABBV Relative Value
Base Case
137.01 USD
Overvaluation 18%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

5.5
P/S
P/S
Price to Sales
5.5
vs History
3
vs Industry
63
Median 3Y
4.4
Median 5Y
4
Industry
7.9
Forward
5.3
More Details
61.5
P/E
P/E
Price to Earnings
61.5
vs History
3
vs Industry
3
Median 3Y
28.1
Median 5Y
22.6
Industry
26.2
Forward
14.7
More Details
13
P/OCF
P/OCF
Price to OCF
13
vs History
3
vs Industry
10
Median 3Y
10.3
Median 5Y
9.8
Industry
22.1
More Details
18.5
P/FCFE
P/FCFE
Price to FCFE
18.5
vs History
28
vs Industry
7
Median 3Y
18.4
Median 5Y
15.6
Industry
20.2
More Details
28.6
P/B
P/B
Price to Book Value
28.6
vs History
3
vs Industry
2
Median 3Y
16.2
Median 5Y
14.4
Industry
2.5
More Details
6.2
EV/S
EV/S
Enterprise Value to Sales
6.2
vs History
6
vs Industry
50
Median 3Y
5.3
Median 5Y
5.1
Industry
7.2
Forward
6
More Details
9.3
EV/GP
EV/GP
Enterprise Value to Gross Profit
9.3
vs History
3
vs Industry
42
Median 3Y
7.7
Median 5Y
7.4
Industry
8.9
More Details
13.3
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
13.3
vs History
9
vs Industry
9
Median 3Y
10.8
Median 5Y
10.7
Industry
4.9
Forward
12.5
More Details
20.3
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
20.3
vs History
4
vs Industry
6
Median 3Y
15.6
Median 5Y
15.4
Industry
4.7
Forward
13
More Details
14.7
EV/OCF
EV/OCF
Enterprise Value to OCF
14.7
vs History
9
vs Industry
10
Median 3Y
12.8
Median 5Y
12.5
Industry
5.3
More Details
15.2
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
15.2
vs History
9
vs Industry
8
Median 3Y
13.3
Median 5Y
13
Industry
3.1
More Details
3.7
EV/IC
EV/IC
Enterprise Value to IC
3.7
vs History
4
vs Industry
37
Median 3Y
2.8
Median 5Y
2.9
Industry
4.9
More Details

Multiples Across Competitors

ABBV Competitors Multiples
Abbvie Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Abbvie Inc
NYSE:ABBV
296.3B USD 5.5 61.5 13.3 20.3
US
Amgen Inc
NASDAQ:AMGN
146.2B USD 5.2 21.8 16.2 24.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
103.3B USD 10.5 28.5 22.8 23.9
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
99.2B USD 7.6 25.1 16.7 18.3
AU
CSL Ltd
ASX:CSL
134.5B AUD 6.2 35.4 21.4 26.6
US
Gilead Sciences Inc
NASDAQ:GILD
83.6B USD 3.1 14.8 8.1 10.4
US
Seagen Inc
NASDAQ:SGEN
43.1B USD 18.8 -57.5 -61.9 -55.8
US
Moderna Inc
NASDAQ:MRNA
41.6B USD 6.1 -8.8 -9.3 -7.9
US
Biogen Inc
NASDAQ:BIIB
29.3B USD 3 25.2 13.8 17.1
KR
Celltrion Inc
KRX:068270
37.2T KRW 16.9 68.6 42.6 58.6
IE
Horizon Therapeutics PLC
NASDAQ:HZNP
26.6B USD 7.3 60.8 27.9 47

See Also

Summary
ABBV intrinsic value, competitors valuation, and company profile.
DCF Valuation
ABBV stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ABBV stock valuation using valuation multiples.
Wall Street Estimates
ABBV price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ABBV stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 131,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.